Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Financial Officer
-
Stock Symbol
-
AMLX on Nasdaq
James M. Frates - trading volume in the past year for Amylyx Pharmaceuticals, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
233K |
$592K |
$2.53 |
Sep 12, 2024 |
Direct |
|
|
| Common Stock |
11.1K |
$28.1K |
$2.53 |
Sep 12, 2024 |
By Trust |
|
|
| Stock Option (right to buy) |
120K |
|
|
Apr 16, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.